You are here: Industry Insights > Jubilant Life Sciences

News List

Jubilant Life Sciences to focus on operational, financial performance in near-term expresspharma
August 25, 2020
To tide over the COVID-19 pandemic led crisis, the company in the near-term is deferring its major CAPEX plans, informs annual report.
Jubilant Life Sciences launches JUBI-R for COVID-19 treatment expresspharma
August 04, 2020
The company will make the drug available to over 1,000 hospitals providing COVID-19 treatment in India through its distribution network.
Jubilant Life Sciences posts Rs 260.49 cr profit for Jan-Mar expresspharma
June 03, 2020
Drug firm Jubilant Life Sciences reported a consolidated net profit of Rs 260.49 crore for the quarter ended on March 31, 2020, driven by robust sales in the pharmaceuticals segment.
Jubilant Life Sciences and Gilead sign agreement for Remdesivir expresspharma
May 13, 2020
Jubilant will now have the right to receive a technology transfer of the Gilead manufacturing process to scale up production to enable expedited access of the medicine to COVID-19 patients upon approvals by regulatory authorities in respective countries.
Jubilant Life Sciences contributes Rupees 5 Crores to the PM Cares fund expresspharma
April 26, 2020
The contribution of Jubilant Life Sciences, along with all its subsidiaries, includes one day gross salary of its 5300 employees.
No traces of COVID-19 virus found in the imported raw material: Jubilant Life Sciences expresspharma
April 20, 2020
None of the employees tested positive so far travelled overseas in the last six month, the company announced in a press release.
Jubilant Life Sciences posts Q1 FY18 consolidated revenue of Rs 1,596 cr expressbpd
July 19, 2017
Pharmaceuticals revenue was recorded at Rs 818 crore, contributing 51 per cent to the revenues
Jubilant Life Sciences receives US FDA approval for Bupropion Hydrochloride tablets expressbpd
July 10, 2017
Bupropion Hydrochloride is the generic version of Wellbutrin XL of Valeant and is used for the treatment of major depressive disorder and prevention of seasonal affective disorder